US Patent Issued to Line 6 Biotechnology on March 25 for "Methods and agents for the treatment of ocular disease" (Australian Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,390, issued on March 25, was assigned to Line 6 Biotechnology Inc. (Seattle).

"Methods and agents for the treatment of ocular disease" was invented by Brian W. Ziegelaar (Brisbane, Australia) and Garry L. Redlich (Brisbane, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates generally to methods and agents for treating an ocular disease or disorder. More particularly, the present disclosure relates to the use of CD14 antagonist antibodies for treating an ocular disease or disorder."

The patent was filed on Jan. 27, 2023, under Application No. 18/160,355.

*For further information, including images, charts and tables, p...